The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-efficiency and expanded access modeling of toripalimab versus pembrolizumab in locally advanced or metastatic nonsquamous non-small cell lung cancer.
 
Karen MacDonald
Employment - Matrix45
Leadership - Matrix45; Matrix45 (I)
Stock and Other Ownership Interests - Matrix45; Matrix45 (I)
Research Funding - Coherus BioSciences (Inst)
 
Marc Pondel
Employment - Coherus BioSciences
Leadership - Coherus BioSciences
Stock and Other Ownership Interests - Coherus BioSciences
Research Funding - Coherus BioSciences
Travel, Accommodations, Expenses - Coherus BioSciences
Other Relationship - Coherus BioSciences
 
Ivo Abraham
Employment - Matrix45; Matrix45 (I)
Leadership - Matrix45 (I)
Stock and Other Ownership Interests - Matrix45; Matrix45 (I)
Consulting or Advisory Role - Matrix45 (I)
Speakers' Bureau - Matrix45
Research Funding - Matrix45; Matrix45 (I)
Patents, Royalties, Other Intellectual Property - Book royalties
(OPTIONAL) Uncompensated Relationships - Matrix45